Every healthcare professional involved in the care of patients with chronic obstructive pulmonary disease understands the challenge. COPD is one of the world’s leading causes of illness and death, affecting more than 300 million people and placing an enormous burden on healthcare systems. Although treatment options have improved significantly over recent decades, clinicians continue to face a fundamental problem. They mostly rely on diagnostic measurements that do not fully capture the disease’s complexity. For many years, a simple form of spirometry has been the cornerstone of COPD diagnosis and management. The ratio of forced expiratory volume in one second and forced vital capacity is relatively easy and inexpensive to measure. It is therefore widely available and is supported by decades of clinical experience. This ratio has become so firmly established as a measure of the disease that it is virtually impossible to imagine COPD assessment without it.

Imagine sitting across the kitchen table from someone you have known for decades. They begin telling you about their day, but something has changed. Their words are slower than they once were. Some sounds are blurred together, others seem to disappear entirely. You know the person well. You know the stories they are likely to tell and the expressions they often use. Yet despite all of that familiarity, you find yourself asking them to repeat themselves again and again.

For decades, doctors have puzzled over a strange and often misunderstood condition called normal pressure hydrocephalus. People with the disorder may begin to shuffle when they walk, struggle with memory, or lose bladder control. Brain scans reveal enlarged fluid-filled spaces called ventricles, yet the pressure inside the skull often appears surprisingly normal. It is a medical paradox that has challenged neurologists and neurosurgeons since the condition was first described in the 1960s. Now, new research is offering a radically different way of thinking about what may actually be happening inside the brain. Rather than viewing normal pressure hydrocephalus as a simple problem of fluid buildup, researchers are beginning to see it as a disorder of energy, rhythm, and pulsation.

When a new medical test reaches a clinic or laboratory, most people focus on the technology itself. They think about the machine, the test kit, or the scientific breakthrough that makes diagnosis possible. Yet behind every successful diagnostic test lies something far less visible but equally important: the biological specimens used to develop and validate it. Without the right samples, even the most promising diagnostic innovation can fail. A test may appear accurate in the laboratory but perform poorly in real-world settings. It may work well for one patient population but struggle in another. It may detect a disease in some regions of the world while missing important variations elsewhere.

For centuries, sleep has remained one of humanity’s greatest biological mysteries. We spend roughly a third of our lives doing it, yet scientists are still trying to fully understand why the brain insists upon sleep. It seems clear that sleep restores the body, sharpens memory, regulates emotions, and keeps countless internal systems in balance. But one major problem has always complicated sleep research: most experiments focus on what happens when sleep is taken away. That approach has taught researchers a great deal. Sleep deprivation has been linked to poor concentration, weakened immune function, emotional instability, and a long list of health problems. Yet asking what happens when sleep is removed only tells part of the story. It is a little like studying hunger by starving people without ever exploring what happens when they are exceptionally well fed.

The human heart beats with a rhythm so steady that most of us rarely stop to consider it. Each pulse carries oxygen, sustains life, and quietly reflects the intricate biological systems that keep us alive. However, this familiar rhythm requires a delicate electrical balance. When that balance is disturbed, the consequences can be sudden and severe. Among the most striking examples is Long QT syndrome, a condition that can lurk silently until it triggers a dangerous arrhythmia or even sudden cardiac death.

The human brain is often described as one of the most complex objects in the known universe. Yet even within this astonishing organ, a small curved structure deep in the temporal lobe has drawn extraordinary scientific attention for decades. This structure, the hippocampus, plays a central role in memory formation, learning, emotional processing, and spatial navigation. It is also one of the brain regions most vulnerable to disease.

Age-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older adults worldwide. In Asia, where populations are ageing rapidly, its impact is particularly profound. For many, the disease quietly erodes central vision, making everyday activities such as reading, driving, and recognising faces increasingly difficult. Against this backdrop, the Translational Asian Age-related Macular Degeneration Programme, or TAAP for short, has emerged as a bold and ambitious effort to confront the disease head-on. Now in its second phase, TAAP-2 represents a significant evolution in both scientific scope and clinical ambition.

Cannabis legalization in Canada was meant to bring transparency, consistency, and safety to a rapidly growing industry. Products sold through regulated channels are tested, packaged, and monitored under strict federal rules. For many consumers, especially medical patients, that regulatory seal offers reassurance that the product they are using has been carefully vetted for health risks. But new research at McGill University suggests that potentially harmful fungal toxins can persist in cannabis products even after they undergo standard decontamination processes and meet existing regulatory thresholds. Their findings raise important questions about whether current definitions of cannabis safety are sufficient to protect consumers, particularly those in higher-risk groups.

Light is something we encounter every day, so familiar that it rarely inspires a second thought. Yet beneath its apparent simplicity lies a remarkable complexity. Light can carry information in its brightness and color, but also in its polarization and phase, subtle properties that describe how its waves oscillate and interact. For decades, these hidden dimensions of light have remained largely untapped in medicine. Now, a growing body of research is beginning to reveal their extraordinary potential.